OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, published by Mary Ann Liebert, Inc., is a leading peer-reviewed journal dedicated to the field of integrative biology, encompassing Biochemistry, Biotechnology, Genetics, Molecular Biology, and Medicine. With an ISSN of 1536-2310 and E-ISSN of 1557-8100, this esteemed journal stands out with its commitment to advancing scientific knowledge and research within its scope, particularly effective from its inception in 2002 through to 2024. The journal holds a commendable position in various Scopus ranks, notably achieving a Q2 quartile in Biotechnology and Medicine (miscellaneous), and continues to exemplify rigorous scholarship with an impactful focus on cross-disciplinary integration. Although not an open-access publication, OMICS ensures that its readership has access to significant findings that shape contemporary biological discourse. Researchers, professionals, and students alike are encouraged to contribute to and explore this journal, as it not only advances knowledge but also fosters collaboration among diverse scientific communities.

Biochemistry and Biophysics Reports, published by Elsevier, serves as a vital platform for the dissemination of innovative research in the fields of biochemistry, biophysics, cell biology, and molecular biology. With an Open Access model initiated in 2015, this journal aims to facilitate the unimpeded sharing of knowledge, allowing researchers, professionals, and students free access to significant findings and developments. The journal has established a presence in the academic community, currently holding a Q3 ranking in Biochemistry, Q2 in Biophysics, alongside its Q3 standings in both Cell Biology and Molecular Biology categories for 2023. These metrics underscore its commitment to quality and relevance, garnering attention with Scopus ranks reflecting its emerging influence. Located in the Netherlands, Biochemistry and Biophysics Reports continues to foster dialogue and collaboration among the scientific community through high-quality research outputs, contributing to advancements in understanding the intricate biochemical processes and biophysical principles that underpin life sciences.

BIOTECHNOLOGY ADVANCES is a premier, peer-reviewed journal published by PERGAMON-ELSEVIER SCIENCE LTD, dedicated to advancing knowledge in the rapidly evolving fields of biotechnology and bioengineering. With an ISSN of 0734-9750 and an E-ISSN of 1873-1899, this esteemed journal covers a wide spectrum of topics relevant to applied microbiology, molecular biology, and biochemical innovation. Recognized for its academic rigor, it holds a distinguished position in the top quartile (Q1) in multiple categories, including Applied Microbiology and Biotechnology, Bioengineering, and Biotechnology, further evidenced by its high rankings in Scopus, where it ranks #3/127 in Applied Microbiology and Biotechnology and #7/311 in Biotechnology. Researchers and professionals in the field value the journal not only for its comprehensive coverage of cutting-edge research but also for its commitment to disseminating critical findings and fostering collaboration. While BIOTECHNOLOGY ADVANCES currently operates under a subscription model, its potential impact on future innovations in biotechnology cannot be overstated, making it an essential resource for anyone interested in the forefront of biotechnological advancements.

Welcome to Critical Reviews in Biochemistry and Molecular Biology, a premier academic journal published by Taylor & Francis Ltd, dedicated to advancing the fields of biochemistry and molecular biology. With an impressive impact factor and a Q1 ranking in both Biochemistry and Molecular Biology for 2023, this journal serves as a vital resource for researchers, professionals, and students eager to engage with cutting-edge reviews and analyses that synthesize the latest developments in these dynamic areas of study. Since its inception in 1972, the journal has maintained a commitment to high-quality scholarship, providing a platform for critical discussions that accelerate the discovery and understanding of biochemical processes and molecular interactions. Although not open access, its robust editorial peer-review process ensures that published articles meet the highest standards of scientific rigor, making it a trusted source for the scientific community. As we continue to converge toward 2024, we invite you to explore the extensive array of topics and findings that have shaped contemporary biochemistry and molecular biology.

AIMS Biophysics, published by the American Institute of Mathematical Sciences (AIMS), is an esteemed open-access journal dedicated to advancing the fields of biophysics, biochemistry, molecular biology, and structural biology. Launched in 2014, this journal provides a platform for researchers and professionals to disseminate high-quality research findings that contribute to the understanding of complex biological systems at the molecular level. With an ISSN of 2377-9098, AIMS Biophysics is indexed in Scopus, where it ranks in the fourth quartile across several categories, reflecting its commitment to addressing important issues within the scientific community. The journal aims to foster interdisciplinary collaboration and innovation through the publication of original research, reviews, and methodologies that advance the field. The open-access model ensures that cutting-edge research is freely available, promoting global access to scientific knowledge and enhancing visibility for authors. Nestled in the vibrant scientific landscape of the United States, AIMS Biophysics is poised to impact the evolving discourse in biophysics and related areas as it continues through its convergence period from 2014 to 2024.

Current Bioinformatics, an esteemed journal published by Bentham Science Publishers Ltd, serves as a pivotal platform for the dissemination of cutting-edge research in the fields of bioinformatics, biochemistry, computational mathematics, genetics, and molecular biology. With an ISSN of 1574-8936 and an E-ISSN of 2212-392X, this journal has established itself as a vital resource for researchers, professionals, and students keen on exploring interdisciplinary approaches to biological data analysis. Its prominence is reflected in its quartile rankings for 2023, where it stands in Q3 for biochemistry and computational mathematics, alongside Q4 rankings in genetics and molecular biology. Current Bioinformatics, located in the United Arab Emirates and converging from 2007 to 2024, aims to foster innovation in the field by presenting original research articles, reviews, and case studies that drive forward our understanding of complex biological systems through computational techniques. This journal is an integral resource for those wishing to stay at the forefront of bioinformatics research and applications.

Bioinformatics and Biology Insights is a premier open-access journal dedicated to advancing the frontiers of bioinformatics and biology. Published by SAGE Publications Ltd, this journal is a leading platform for disseminating high-quality research that integrates computational methods with biological insights. Since its inception in 2007, the journal has garnered significant recognition, reflecting its commitment to excellence, as evidenced by its impressive impact factor and a strong presence across multiple quartiles in applied mathematics, biochemistry, and computational sciences. With a rank of Q1 in both Applied Mathematics and Computational Mathematics and various other notable rankings in related fields, it serves as an essential resource for researchers, professionals, and students seeking cutting-edge knowledge and innovations. The journal's open-access model ensures that findings are readily available, fostering collaboration and advancement in this dynamic field. Through its comprehensive scope and rigorous peer-review process, Bioinformatics and Biology Insights continues to play a pivotal role in shaping the future of biological research and computational methodologies.

IUBMB LIFE is a prestigious, peer-reviewed journal published by WILEY, dedicated to advancing the fields of biochemistry, molecular biology, and cell biology. With an impressive impact factor and consistently ranked in the Q1 and Q2 categories across multiple relevant disciplines—including Biochemistry, Genetics, and Clinical Biochemistry—this journal has established itself as a leading platform for disseminating innovative research and critical reviews that propel scientific discovery. The journal spans a converged publication period from 1999 to 2024, providing comprehensive insights into the dynamic landscape of biochemical research. Researchers, professionals, and students alike are invited to explore its Open Access options, ensuring that groundbreaking studies are accessible to a global audience. As it continues to shape the future of life sciences, IUBMB LIFE remains a vital resource for those seeking to enrich their understanding and contribute to these rapidly evolving fields.

ACS Bio & Med Chem Au, published by the esteemed American Chemical Society, stands at the forefront of interdisciplinary research within the realms of biochemistry, drug discovery, pharmaceutical sciences, and molecular biology. With an impressive Impact Factor indicative of its rigorous academic standards and significant contributions to the field, this open-access journal is committed to disseminating high-quality research that drives innovation and advancements in biosciences and medicinal chemistry. Since its inception in 2021, the journal has rapidly earned recognition, achieving a commendable Q1 ranking in multiple categories, including Biochemistry, Drug Discovery, and Pharmaceutical Science, while also making strides in Molecular Biology. Researchers, professionals, and students alike can explore pioneering studies that bridge gaps between laboratory research and clinical applications, fostering collaborative efforts towards novel therapeutic strategies. With a focus on enhancing accessibility and engagement within the scientific community, ACS Bio & Med Chem Au is poised to impact the future of biomedical research significantly.

TRENDS IN BIOCHEMICAL SCIENCES is a premier academic journal published by CELL PRESS, focusing on the latest advancements and insights in the dynamic fields of biochemistry and molecular biology. With an ISSN of 0968-0004 and an E-ISSN of 1362-4326, this journal has established itself as a leading source of high-impact research, boasting an impressive Q1 category ranking in both Biochemistry and Molecular Biology as of 2023. The journal's Scopus Ranks further highlight its significance, placing it in the top 3% and 4% of its respective fields, emphasizing its role as a vital platform for disseminating innovative research. Published since 1976 and continuing through 2024, TRENDS IN BIOCHEMICAL SCIENCES provides a comprehensive overview of the latest trends, methods, and applications, helping researchers, professionals, and students stay at the forefront of their disciplines. Although it offers traditional access options, the journal's rich content and authoritative analysis make it a must-read for those pursuing cutting-edge biochemical research.